van der Knaap, Noa http://orcid.org/0000-0002-7067-3345
Franx, Bart A. A. http://orcid.org/0000-0002-6410-3805
Majoie, Charles B. L. M. http://orcid.org/0000-0002-7600-9568
van der Lugt, Aad http://orcid.org/0000-0002-6159-2228
Dijkhuizen, Rick M. http://orcid.org/0000-0002-4623-4078
,
Funding for this research was provided by:
Dutch Heart Foundation (CVON2015-01, CVON2015-01, CVON2015-01, CVON2015-01)
Brain Foundation, Netherlands (HA2015.01.06, HA2015.01.06, HA2015.01.06, HA2015.01.06)
Ministerie van Economische Zaken (LSHM17016, LSHM17016, LSHM17016, LSHM17016)
Article History
Received: 28 October 2022
Revised: 22 December 2022
Accepted: 23 December 2022
First Online: 19 January 2023
Declarations
:
: N.v.d.K. and B.A.A.F. have no relevant financial or non-financial interests to disclose. C.B.L.M.M. received funds from CVON/Dutch Heart Foundation, the European Commission, Healthcare Evaluation Netherlands, TWIN Foundation and Stryker (unrelated to this project; all paid to institution) and is shareholder of Nicolab. A.v.d.L. received funds from CVON/Dutch Heart Foundation, the European Commission, Dutch Brain Foundation, Stryker, Medtronic, Penumbra, Cerenovus, Thrombolytic Science (unrelated to this project; all paid to the institution) and he serves on the DSMB of ESCAPE-NEXT. R.M.D. received funds from ZonMw, the European Commission, the Dutch Research Council (NWO) and Open Technology Programme (TTW; partly financed by NWO), and is an editorial board member of Translational Stroke Research.
: The funding sources were not involved in study design, monitoring, data collection, statistical analyses, interpretation of results, or manuscript writing.